Never miss a story
Sign up for our free daily morning email...
...and afternoon text update
×

(Pexels file photo)

Now a few months into the vaccine distribution effort, Austin-based Benchmark Research is working toward developing a COVID-19 vaccine safety trial for children ranging from ages six months to 11 years old.


The trial would study the Moderna vaccine's efficacy in kids and be a continuation of its teens trial studying ages 12-17, which is already underway in Austin, as first reported by KXAN.

The trial has not announced a start date or timeline but Benchmark Research officials have said they are still researching and will take as many safety precautions as possible.

This study would be reflective of the earlier announced teen trial and would use similar doses. For every two authentic doses administered to the children, one child will receive a placebo dose.

This is not the first vaccine trial done on children—Austin Regional Clinic enrolled teenage participants for a Pfizer vaccine trial back in October and plans to hold another trial for 5-11 year olds sometime this summer.

Moderna's teen trial began on Jan. 29 and is still accepting applicants. Benchmark Research is currently holding a number of trials and is also actively looking for adults to participate. For more information, click here

Popular

Following the purchase of a converted 34-foot-long van, Addicus' Legacy Dog Rescue's pups headed to their forever homes in style during its maiden voyage last week.

Keep Reading Show less

Ingredients:

  • 1 1/2 oz Tito's Handmade Vodka
  • 2 oz sparkling water
  • 1/2 oz coconut sugar simple syrup
  • 1/2 oz lemon juice
  • 2-4 kiwi slices, peeled
  • 2 basil leaves
Directions: Muddle kiwi slices in a shaker tin. Add Tito's Handmade Vodka, syrup, lemon juice, basil and ice. Shake and strain over fresh ice in a glass. Top with sparkling water. Garnish with a basil leaf and kiwi slice.
(Austin Public Health/Twitter)

Eighty-seven providers in Travis County will receive a total of 75,540 doses of the COVID-19 vaccine for the week of March 8 as part of the 13th weekly allocation, a nearly 62% increase compared to last week's. The significant increase is largely due to inclusion of the new Johnson & Johnson vaccine, which received an emergency use authorization from the FDA last weekend.

The bulk will go to hub providers Austin Public Health and UT Health Austin, the clinical wing of Dell Medical School, as well as to Seton Medical Center, which will receive the largest share of this week's shipment. These three providers will either receive doses from Moderna or Pfizer.

Keep Reading Show less